| Full Name | Gary M Watts |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 1034 N 500 W, Provo, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528014792 | NPI | - | NPPES |
| 870284448WA1 | Other | UT | EMIA |
| 159847 | Other | UT | DMBA |
| 107006211103 | Other | UT | IHC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 155859-1205 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gary M Watts, MD 283 E 930 S, Orem, UT 84058-5001 Ph: (801) 225-6246 | Gary M Watts, MD 1034 N 500 W, Provo, UT 84604-3380 Ph: (801) 373-7850 |
News Archive
A team of University of California, San Diego School of Medicine researchers has discovered that common intestinal bacteria appear to promote tumor growths in genetically susceptible mice, but that tumorigenesis can be suppressed if the mice are exposed to an inhibiting protein enzyme.
Cognitive behavioral therapy in addition to medication improves the long-term success of treatment for children and adolescents suffering from depression, a new UT Southwestern Medical Center study indicates.
The National Hispanic Science Network on Drug Abuse awarded the National Award of Excellence in Research by a New Investigator to Alice Cepeda, sociology professor and associate director of the Center for Drug and Social Policy Research, Graduate College of Social Work, University of Houston. Cepeda will be honored Sept. 30 at the organization's annual conference in New Orleans.
Subretinal transplantation of retinal pigment epithelium derived from human embryonic stem cells appears to be a well-tolerated means of treating age-related macular degeneration and Stargardt's macular dystrophy, suggest two open-label phase I/II studies.
Infinity Pharmaceuticals, Inc. today announced Phase 1 data from an ongoing study of IPI-145, its potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma in patients with advanced hematologic malignancies, or potentially fatal blood cancers.
› Verified 6 days ago
Dr. Daniel Lyman Corey, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-225-6246 Fax: 801-225-1525 | |
Samuel Lynn Southam, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-357-7850 Fax: 801-357-7626 | |
Scott D Valadez, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 500 W, Suite 112, Provo, UT 84604 Phone: 801-812-4624 Fax: 801-812-4699 | |
Mark S Asay, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-373-7850 | |
Dr. Derek Scott Bergeson, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 500 W, Attn Credentialing, Provo, UT 84604 Phone: 801-354-8225 Fax: 801-418-0941 | |
Dalton H Wright, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 500 W, Suite 112, Provo, UT 84604 Phone: 801-812-4624 Fax: 801-812-4699 | |
John S Collins, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-373-7850 |